Sedation: Clinical Trials

4 trials for Sedation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Terminated 4

Follow Sedation: new trials by email Literature Review of Sedation trials Research Report on Sedation

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery
Remimazolam Besylate, Propofol, Midazolam - Sedation, ICU
Phase 4TerminatedNanfang Hospital, Southern Medical University1172022-03-162026-07-02
Deep Brain Stimulation (DBS) Sedation
Remifentanil, Propofol, Dexmedetomidine - Brain, Sedation
Phase 4TerminatedUniversity of Wisconsin, Madison202017-12-012024-07-05
A Study Comparing Two Analgesia/Sedation Regimens, Remifentanil/Propofol Versus Sufentanil/Propofol In Mechanically Ventilated Intensive Care Patients Requiring Analgesia And Sedation.
Sufentanil, Remifentanil - Analgesia, Sedation
Phase 4TerminatedGlaxoSmithKline1642007-01-012018-04-03
Dexmedetomidine for Postoperative Sedation in Patients Undergoing Repair of Thoracoabdominal Aortic Aneurysms
Dexmedetomidine, Normal Saline - Sedation, Respiration, Artificial
Phase 4TerminatedMassachusetts General Hospital2007-01-012009-09-22

Narrower conditions

Agnosia (1)  ·  Aortic Aneurysm, Thoracoabdominal (1)  ·  Delirium (1)  ·  Mouth Neoplasms (1)  ·  Respiratory Aspiration (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (2)  ·  Aneurysm (1)  ·  Aortic Aneurysm (1)  ·  Aortic Aneurysm, Abdominal (1)  ·  Aortic Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Confusion (1)  ·  Head and Neck Neoplasms (1)  ·  Mental Disorders (1)  ·  Mouth Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurocognitive Disorders (1)

Interventions

Dexmedetomidine (2)  ·  Propofol (2)  ·  Remifentanil (2)  ·  Midazolam (1)  ·  Saline Solution (1)  ·  Sufentanil (1)

Sponsors

GlaxoSmithKline (1)  ·  Massachusetts General Hospital (1)  ·  Nanfang Hospital, Southern Medical University (1)  ·  University of Wisconsin, Madison (1)

Countries

United States (2)  ·  China (1)  ·  Germany (1)

Top investigators

Corey A Amlong, MD (1)  ·  Ulrich Schmidt, MD,PhD (1)